Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Certain growth factors significantly affect hair loss in women with telogen effluvium.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

Weight loss can cause temporary hair loss, especially in women and older adults.

Some medications, including retinoids, antifungals, and psychotropic drugs, can cause reversible hair loss if stopped or doses are reduced.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

The supplement with amino acids, iron, selenium, and marine hydrolyzed collagen improved hair growth more than drug treatment alone, with most people tolerating it well.

The food supplement improved hair growth and strength in people with a certain type of hair loss and had no major side effects.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Changing six essential health practices can help prevent excessive hair shedding.

Horizontally sectioned scalp biopsies are more reliable for diagnosing hair loss in women when three samples are taken instead of one.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Low-level laser therapy helps increase hair growth in female pattern hair loss but not in telogen effluvium.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

A critically ill boy experienced hair loss likely due to the stress of his medical treatments, but his hair regrew completely in 1.5 months.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Syphilis chancres can be atypical, and fiber implantation for baldness is risky and often fails.

Low iron levels are strongly linked to chronic hair loss in women.

L-Cystine and L-Cystine with Kera-Diet® safely improved hair and nail quality in healthy women.

The workshop aimed to improve hair loss disorder diagnosis and understanding.